Language
English
Publication Date
5-1-2022
Journal
Reviews in Cardiovascular Medicine
DOI
10.31083/j.rcm2305157
PMID
39077617
PMCID
PMC11273972
PubMedCentral® Posted Date
4-27-2022
PubMedCentral® Full Text Version
Post-print
Abstract
This review focuses on the strengths and limitations of conventional and high-sensitivity troponin in the evaluation of patients with suspected acute coronary syndromes. High-sensitivity troponin (hsTn) assays represent a significant innovation over prior generation troponin assays. Owing to superior analytical precision, hsTn permits more rapid "rule-in" and "rule-out" of myocardial infarction. Furthermore, hsTn assays, in properly implemented clinical pathways, permit a reduction in the portion of patients requiring extended observation and testing.
Keywords
troponin, high sensitivity troponin, chest pain, acute coronary syndrome, biomarkers
Published Open-Access
yes
Recommended Citation
Stephen Boone and W Frank Peacock, "Contemporary Biomarker Strategies for Patients with Chest Pain" (2022). Faculty and Staff Publications. 516.
https://digitalcommons.library.tmc.edu/baylor_docs/516
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Biology Commons, Medical Sciences Commons, Medical Specialties Commons